|
OMIM |
Link |
Information gain |
01 |
|
weill-marchesani syndrome, autosomal dominant
|
[NCBI]
|
0.000136157
|
|
|
weill-marchesani syndrome, autosomal recessive
|
[NCBI]
|
0.000123712
|
|
|
drug metabolism, poor, cyp2c19-related
|
[NCBI]
|
0.000123712
|
|
|
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis
|
[NCBI]
|
0.000120843
|
|
|
liddle syndrome
|
[NCBI]
|
0.000116105
|
|
|
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency
|
[NCBI]
|
0.00011061
|
|
|
pyruvate kinase deficiency of red cells
|
[NCBI]
|
8.71153e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
7.41954e-05
|
|
|
TERT
|
[NCBI]
|
7.1537e-05
|
|
|
DMD
|
[NCBI]
|
5.80382e-05
|
|
|
OAZ2
|
[NCBI]
|
5.32399e-05
|
|
|
CDKN2A
|
[NCBI]
|
4.5289e-05
|
|
|
SMARCD1
|
[NCBI]
|
4.49931e-05
|
|
|
SMARCD2
|
[NCBI]
|
4.49931e-05
|
|
|
SMARCC2
|
[NCBI]
|
4.49931e-05
|
|
|
SMARCC1
|
[NCBI]
|
4.49931e-05
|
|
|
UBE2S
|
[NCBI]
|
4.49931e-05
|
|
|
SMARCD3
|
[NCBI]
|
4.18808e-05
|
|
|
CHRNA9
|
[NCBI]
|
3.986e-05
|
|
|
CLN6
|
[NCBI]
|
3.83575e-05
|
|
|
OAZ1
|
[NCBI]
|
3.71603e-05
|
|
|
MOCS2
|
[NCBI]
|
3.53128e-05
|
|
|
GOPC
|
[NCBI]
|
3.53128e-05
|
|
|
ROS1
|
[NCBI]
|
3.53128e-05
|
|
|
SCNN1B
|
[NCBI]
|
3.02759e-05
|
|
|
FGF3
|
[NCBI]
|
2.96334e-05
|
|
|
CYP2C19
|
[NCBI]
|
2.93366e-05
|
|
|
CLCN5
|
[NCBI]
|
2.9054e-05
|
|
|
PAX5
|
[NCBI]
|
2.87842e-05
|
|
|
PAX8
|
[NCBI]
|
2.85262e-05
|
|
|
CYP11B1
|
[NCBI]
|
2.8279e-05
|
|
|
ITGA2B
|
[NCBI]
|
2.73822e-05
|
|
|
PKLR
|
[NCBI]
|
2.53006e-05
|
|
|
INSL3
|
[NCBI]
|
2.33319e-05
|
|
|
KCNQ1
|
[NCBI]
|
2.28312e-05
|
|
|
FBN1
|
[NCBI]
|
1.91737e-05
|
|
|
ABCC8
|
[NCBI]
|
1.89724e-05
|
|
|
hemophilia a
|
[NCBI]
|
1.6746e-05
|
|
|
DMD
|
[NCBI]
|
1.57352e-05
|
|
|
PRNP
|
[NCBI]
|
1.55151e-05
|
|
|
phenylketonuria
|
[NCBI]
|
1.51244e-05
|
|
|
BCR
|
[NCBI]
|
1.46889e-05
|
|
|
ACPP
|
[NCBI]
|
1.44609e-05
|
|
|
TF
|
[NCBI]
|
8.20756e-06
|
|
|
GFAP
|
[NCBI]
|
1.77783e-06
|
|
|
RA
|
[NCBI]
|
9.82497e-07
|
|